S
EDIT icon

SignatureFD’s Editas Medicine EDIT Stock Holding History

SignatureFD’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.21K Sell
1,300
-140
-10% -$409 ﹤0.01% 2915
2026
Q1 		$3.56K Hold
1,440
– – ﹤0.01% 2889
2025
Q4 		$2.95K Hold
1,440
– – ﹤0.01% 2865
2025
Q3 		$5K Hold
1,440
– – ﹤0.01% 2664
2025
Q2 		$3.17K Hold
1,440
– – ﹤0.01% 2735
2025
Q1 		$1.67K Hold
1,440
– – ﹤0.01% 2926
2024
Q4 		$1.83K Sell
1,440
-7,886
-85% -$20.1K ﹤0.01% 2899
2024
Q3 		$31.8K Buy
9,326
+7,758
+495% +$33.8K ﹤0.01% 1823
2024
Q2 		$7.32K Buy
1,568
+56
+4% +$316 ﹤0.01% 2387
2024
Q1 		$11.2K Buy
1,512
+4
+0.3% +$33 ﹤0.01% 2260
2023
Q4 		$15.3K Sell
1,508
-903
-37% -$7.93K ﹤0.01% 2058
2023
Q3 		$18.8K Sell
2,411
-50
-2% -$429 ﹤0.01% 1880
2023
Q2 		$20.3K Buy
2,461
+351
+17% +$3.06K ﹤0.01% 1879
2023
Q1 		$15.3K Buy
2,110
+272
+15% +$2.42K ﹤0.01% 2015
2022
Q4 		$16.3K Buy
1,838
+378
+26% +$4.15K ﹤0.01% 1908
2022
Q3 		$18K Buy
1,460
+120
+9% +$1.87K ﹤0.01% 1776
2022
Q2 		$16K Sell
1,340
-65
-5% -$871 ﹤0.01% 1880
2022
Q1 		$27K Sell
1,405
-35
-2% -$651 ﹤0.01% 1686
2021
Q4 		$38K Buy
1,440
+213
+17% +$7.33K ﹤0.01% 1465
2021
Q3 		$50K Sell
1,227
-58
-5% -$3.18K ﹤0.01% 1294
2021
Q2 		$73K Buy
1,285
+1,010
+367% +$37.3K ﹤0.01% 1097
2021
Q1 		$12K Buy
275
+88
+47% +$5.01K ﹤0.01% 1768
2020
Q4 		$13K Buy
187
+40
+27% +$1.64K ﹤0.01% 1598
2020
Q3 		$4K Buy
147
+45
+44% +$1.47K ﹤0.01% 1959
2020
Q2 		$3K Sell
102
-1
-1% -$26 ﹤0.01% 1959
2020
Q1 		$2K Hold
103
– – ﹤0.01% 1924
2019
Q4 		$3K Hold
103
– – ﹤0.01% 1768
2019
Q3 		$2K Hold
103
– – ﹤0.01% 1798
2019
Q2 		$3K Hold
103
– – ﹤0.01% 1672
2019
Q1 		$3K Hold
103
– – ﹤0.01% 1687
2018
Q4 		$2K Hold
103
– – ﹤0.01% 1715
2018
Q3 		$3K Sell
103
-300
-74% -$9.69K ﹤0.01% 1622
2018
Q2 		$14K Buy
403
+100
+33% +$3.54K ﹤0.01% 1280
2018
Q1 		$10K Buy
+303
New +$10.8K ﹤0.01% 1239

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SignatureFD's EDIT Position: Q2 2026 in Review

SignatureFD reduced its Editas Medicine (EDIT) stake by 9.7% in Q2 2026, selling an estimated $409 and leaving 1,300 shares worth $4.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2915.

SignatureFD first reported a position in EDIT in Q1 2018 and has held it in 34 quarters since. The position peaked at $73K in Q2 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • SignatureFD held 1,300 shares of Editas Medicine worth $4.21K as of Q2 2026.
  • SignatureFD sold 140 Editas Medicine shares in Q2 2026, an estimated $409.
  • Editas Medicine made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2915 holding.
  • SignatureFD first reported a position in Editas Medicine in Q1 2018 and has held it in 34 quarters since.
  • SignatureFD's Editas Medicine position peaked at $73K in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.